CLOZAPINE
Substance profile for UNII J60AR2IKIC, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.
Structure render from NCI/CADD chemical resolverSubstance Identity#
- UNII
- J60AR2IKIC
- Preferred term
- CLOZAPINE
- Registry number
- 5786-21-0
- EC number
- 227-313-7
- Ingredient type
- INGREDIENT SUBSTANCE
- Molecular formula
- C18H19ClN4
Structure render from NCI/CADD chemical resolverChemical And Database Identifiers#
- InChIKey
- QZUDBNBUXVUHMW-UHFFFAOYSA-N
- SMILES
- CN1CCN(CC1)C2=NC3=CC(Cl)=CC=C3NC4=CC=CC=C24
- RxCUI
- 2626
- PubChem
- 0
- NCIt
- C28936
- INN ID
- 2612
DailyMed Socrata Ingredients#
Type, DailyMed label, SPL version table| Type | DailyMed label | SPL version |
|---|
| ACTIVE INGREDIENT | These highlights do not include all the information needed to use CLOZARIL safely and effectively. See full prescribing information for CLOZARIL. CLOZARIL® (clozapine) tablets, for oral use Initial U.S. Approval: 1989 | 2 |
| ACTIVE MOIETY | These highlights do not include all the information needed to use CLOZARIL safely and effectively. See full prescribing information for CLOZARIL. CLOZARIL® (clozapine) tablets, for oral use Initial U.S. Approval: 1989 | 2 |
| ACTIVE MOIETY | FAZACLO (CLOZAPINE) TABLET, ORALLY DISINTEGRATING [JAZZ PHARMACEUTICALS, INC.] | 33 |
| ACTIVE INGREDIENT | FAZACLO (CLOZAPINE) TABLET, ORALLY DISINTEGRATING [JAZZ PHARMACEUTICALS, INC.] | 33 |
| ACTIVE INGREDIENT | CLOZARIL (CLOZAPINE) TABLET [NOVARTIS PHARMACEUTICALS CORPORATION] | 22 |
| ACTIVE MOIETY | CLOZARIL (CLOZAPINE) TABLET [NOVARTIS PHARMACEUTICALS CORPORATION] | 22 |
| ACTIVE MOIETY | CLOZAPINE TABLET [TEVA PHARMACEUTICALS USA INC] | 20 |
| ACTIVE INGREDIENT | CLOZAPINE TABLET [TEVA PHARMACEUTICALS USA INC] | 20 |
| ACTIVE MOIETY | CLOZAPINE TABLET [SUN PHARMACEUTICAL INDUSTRIES, INC.] | 14 |
| ACTIVE INGREDIENT | CLOZAPINE TABLET [SUN PHARMACEUTICAL INDUSTRIES, INC.] | 14 |
| ACTIVE MOIETY | CLOZAPINE TABLET [MYLAN PHARMACEUTICALS INC.] | 13 |
| ACTIVE INGREDIENT | CLOZAPINE TABLET [MYLAN PHARMACEUTICALS INC.] | 13 |
| ACTIVE INGREDIENT | CLOZAPINE TABLET, ORALLY DISINTEGRATING [TEVA PHARMACEUTICALS USA INC] | 11 |
| ACTIVE MOIETY | CLOZAPINE TABLET, ORALLY DISINTEGRATING [TEVA PHARMACEUTICALS USA INC] | 11 |
| ACTIVE INGREDIENT | VERSACLOZ (CLOZAPINE) SUSPENSION [JAZZ PHARMACEUTICALS, INC.] | 8 |
| ACTIVE MOIETY | VERSACLOZ (CLOZAPINE) SUSPENSION [JAZZ PHARMACEUTICALS, INC.] | 8 |
| ACTIVE MOIETY | CLOZAPINE TABLET, ORALLY DISINTEGRATING [MYLAN PHARMACEUTICALS INC.] | 6 |
| ACTIVE INGREDIENT | CLOZAPINE TABLET, ORALLY DISINTEGRATING [MYLAN PHARMACEUTICALS INC.] | 6 |
| ACTIVE INGREDIENT | CLOZAPINE TABLET [CARDINAL HEALTH] | 4 |
| ACTIVE MOIETY | CLOZAPINE TABLET [CARDINAL HEALTH] | 4 |
| ACTIVE MOIETY | CLOZAPINE TABLET [MYLAN INSTITUTIONAL INC.] | 4 |
| ACTIVE INGREDIENT | CLOZAPINE TABLET [MYLAN INSTITUTIONAL INC.] | 4 |
| ACTIVE INGREDIENT | CLOZARIL (CLOZAPINE) TABLET [CARDINAL HEALTH] | 2 |
| ACTIVE MOIETY | CLOZARIL (CLOZAPINE) TABLET [CARDINAL HEALTH] | 2 |